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Stelios Tsigkos1*, Segundo Mariz1, Jordi Llinares1, Laura Fregonese1, Stiina Aarum1, Frauke Naumann-Winter2,
Kerstin Westermark3 and Bruno Sepodes4Erratum
After publication of [1] it came to the authors’ attention
that Frauke Naumann-Winter’s name was displayed incor-
rectly. The correct spelling of their name is included in
this erratum.
Author details
1Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus,
Canary Wharf, London E144HB, UK. 2Bundesinstitut für Arzneimittel und
Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, Bonn 53175, Germany.
3Läkemedelsverket, Dag Hammarskjölds vägen 42, Uppsala 75103, Sweden.
4Research Institute for Medicines (iMED.ULisboa), Faculty of Pharmacy,
University of Lisbon, Lisboa 1649-003, Portugal.
Received: 17 July 2015 Accepted: 17 July 2015
References
1. Tsigkos S, Mariz S, Llinares J, Fregonese L, Aarum S, Frauke N, et al.
Establishing medical plausibility in the context of orphan medicines
designation in the European Union. Orphanet Journal of Rare Diseases.
2014; 9:175.* Correspondence: Stylianos.Tsigkos@ema.europa.eu
1Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus,
Canary Wharf, London E144HB, UK
Full list of author information is available at the end of the article
© 2015 Tsigkos et al. Open Access This artic
International License (http://creativecommo
reproduction in any medium, provided you
link to the Creative Commons license, and
Dedication waiver (http://creativecommons
article, unless otherwise stated.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
